A Comparative Study on Virology, Epidemiology, and Clinical Features of SARS and COVID-19

Yanmei Zhao1, Qianying Lu1, Xiangyan Meng1

  • 1Institute of Disaster and Emergency Medicine, Tianjin University, Nankai District, Tianjin, P.R. China.

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the COVID-19 pandemic. This study compares SARS-CoV-2 with SARS-CoV, detailing their virology, epidemiology, and clinical features for better epidemic control.

Area of Science:

  • Virology
  • Epidemiology
  • Clinical Medicine

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, emerged in late 2019.
  • SARS-CoV-2 is a novel zoonotic coronavirus related to SARS-CoV.
  • By October 2021, COVID-19 resulted in over 246 million infections and nearly 5 million deaths globally.

Purpose of the Study:

  • To compare the virology, epidemiology, and clinical features of SARS-CoV and SARS-CoV-2.
  • To identify commonalities and differences between the two coronaviruses.
  • To inform strategies for monitoring and controlling future coronavirus epidemics.

Main Methods:

  • Comparative analysis of scientific literature.
  • Review of virological data.
  • Examination of epidemiological trends and clinical case studies.

Main Results:

  • Detailed comparison of SARS-CoV and SARS-CoV-2 characteristics.
  • Highlighting distinct properties in viral shedding, transmission, and disease progression.
  • Identification of shared pathogenic mechanisms and host responses.

Conclusions:

  • Understanding the distinct and common properties of SARS-CoV and SARS-CoV-2 is crucial.
  • This comparative knowledge aids in developing effective surveillance and intervention strategies.
  • Preparedness for future highly pathogenic human coronavirus outbreaks is enhanced.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.9K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
35.4K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
713